ロード中...
Soluble CD22 as a tumor marker for hairy cell leukemia
CD22 is an important immunotherapeutic target on B-cell malignancies, particularly hairy cell leukemia (HCL), but its soluble extracellular domain, sCD22, has not yet been reported in the blood. By immunoaffinity and enzyme-linked immunosorbent assay techniques using anti-CD22 monoclonal antibodies,...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2532804/ https://ncbi.nlm.nih.gov/pubmed/18596230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-131987 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|